Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Regulatory Roundup

Aug 2, 2013

Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.

Regulatory Roundup

Compounding, tracking legislation moves forward
Jul 2, 2013

Compounding, tracking legislation moves forward

FDA Urges Greater Focus on Contractor Quality

Outsourcing requires clear policies and written agreements with CMOs.
Jul 2, 2013

Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.

Congress Considers Legislation to Secure Drug Supply Chain

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
Jun 2, 2013

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

Regulatory Roundup

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
Jun 2, 2013

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

Regulatory Roundup

May 2, 2013

FDA faces budget crunch; Supreme Court hears key cases

Regulatory Roundup

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
Apr 2, 2013

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.

Manufacturers Under Pressure to Manage Painkillers

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Apr 2, 2013

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here